Results 151 to 160 of about 6,796 (211)

An inducible knock-in mouse model of fibrodysplasia ossificans progressiva shows spontaneous formation of heterotopic ossification. [PDF]

JBMR Plus
Chakkalakal SA, Großmann NZ, Mejías Rivera L, Roberts DW, Pacifici M, Mourkioti F, Shore EM.   +6 more
europepmc   +1 more source

Mutazione del gene di ACVR1 e disfunzioni del sistema stomatognatico

, 2015
Le disfunzioni muscolo-scheletriche del sistema stomatognatico, riconducibili ad alterazioni dell’articolazione temporo-mandibolare, spesso presentano combinazioni di sintomi disfunzionali, come limitazione dei movimenti mandibolari, o anchilosi della mandibola e di sintomi dolorosi, come il mal di testa.
openaire   +1 more source

GNAS/PKA signaling promotes aberrant osteochondral differentiation of Gli1⁺ tendon sheath progenitors. [PDF]

EMBO J
Chen L, Peng C, Chai L, Zhang R, Zhu C, Wang H, Cheng Q, Yan Y, Shen C, Zheng H, Yang J, Fan H, Kan C.   +12 more
europepmc   +1 more source

A sensitive and specific histopathologic prognostic marker for K27M mutant pediatric glioblastomas [PDF]

core   +1 more source

Advancements in mechanisms and drug treatments for fibrodysplasia ossificans progressiva. [PDF]

J Zhejiang Univ Sci B
Zhou Y, Shi C, Sun H.
europepmc   +1 more source

PI3Kα inhibition blocks osteochondroprogenitor specification and the hyper-inflammatory response to prevent heterotopic ossification. [PDF]

Elife
Valer JA, Deber A, Wits M, Pimenta-Lope C, Goumans MJ, Rosa JL, Sánchez-Duffhues G, Ventura F.   +7 more
europepmc   +1 more source

Fibrodysplasia ossificans progressiva: genetic and clinical characterization in a cohort of Polish patients and review of potential therapies. [PDF]

J Appl Genet
Szoszkiewicz A, Szczepanek M, Bukowska-Olech E, Sowińska-Seidler A, Socha M, Jamsheer A.   +5 more
europepmc   +1 more source

Atypical Fibrodysplasia Ossificans Progressiva in a child: A case report. [PDF]

Int J Surg Case Rep
Noufal A, Alsharef Y, Alainein AA, Adi M, Jumaa A, Alfandi A.   +5 more
europepmc   +1 more source

PAXIS: A Randomized, Double-Blind, Placebo-Controlled, Dose-Finding Phase 2 Study (Part 1) Followed by an Open-Label Period (Part 2) to Assess the Efficacy and Safety of Pacritinib in Patients with VEXAS Syndrome. [PDF]

J Clin Med
Beck DB, Heiblig M, Savic S, Ferrada MA, Mekinian A, Chowdhury O, Hammond D, Weeks LD, Gurnari C, Kirino Y, Georgin-Lavialle S, Buckley SA, Garcha R, Harder BG, Koster MJ.   +14 more
europepmc   +1 more source

Quality of life of patients with fibrodysplasia ossificans progressiva [PDF]

, 2015

core   +1 more source